Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2010 5
2013 2
2014 1
2015 1
2016 4
2017 3
2018 2
2019 2
2020 3
2021 4
2022 23
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Ketamine for Adults With Treatment-Resistant Depression or Posttraumatic Stress Disorder: A 2023 Update: Rapid Review [Internet].
Authors; Barbara AM, Xie W, Mahood Q, Hamson A. Authors, et al. Among authors: mahood q. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jan. Report No.: RC1522. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jan. Report No.: RC1522. PMID: 38564542 Free Books & Documents. Review.
Oral Ketorolac for Renal Colic in Outpatient Settings: Rapid Review [Internet].
Authors; Lachance CC, Mahood Q. Authors, et al. Among authors: mahood q. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jan. Report No.: RC1525. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jan. Report No.: RC1525. PMID: 38564537 Free Books & Documents. Review.
Semaglutide for Type 2 Diabetes (2 mg): CADTH Health Technology Review [Internet].
Authors; Jahagirdar D, Mahood Q. Authors, et al. Among authors: mahood q. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Oct. Report No.: RC1507. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Oct. Report No.: RC1507. PMID: 38096343 Free Books & Documents. Review. No abstract available.
Cost-Effectiveness of an RSVpreF Vaccine for Prevention of Respiratory Syncytial Virus Outcomes in Infants: CADTH Health Technology Review [Internet].
Authors; Verbrugghe S, Mahood Q, Tiggelaar S. Authors, et al. Among authors: mahood q. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Aug. Report No.: HE0044. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Aug. Report No.: HE0044. PMID: 37934840 Free Books & Documents. Review. No abstract available.
60 results